外周血sCD14、CD4+T细胞、Th17细胞水平与获得性免疫缺陷综合征合并结核病病人抗病毒治疗效果及预后的关系

    The relationship between the levels of sCD14, CD4+T Cells and Th17 cells in peripheral blood and antiviral treatment effect and prognosis of acquired immune deficiency syndrome patients complicated with tuberculosis

    • 摘要:
      目的: 探讨外周血可溶性分化抗原14(sCD14)、CD4+T细胞、辅助性T细胞17(Th17)水平与病人疗效以及预后的关联,为临床早期识别高危病人、优化治疗策略提供参考。
      方法: 选取获得性免疫缺陷综合征(AIDS)合并结核病(TB)病人102例。根据病人抗逆转录病毒治疗(ART)疗效分为治疗有效组(71例)和疗效不佳组(31例)。所有病人随访2年,102例病人中有22例预后不良,80例预后良好。收集病人一般资料,采用酶联免疫吸附试验(ELISA)检测外周血sCD14水平,采用流式细胞术检测外周血CD4+T细胞计数及Th17细胞比例,采用实时荧光定量PCR法检测血浆HIV载量。采用logistic回归分析AIDS合并TB病人ART治疗疗效的影响因素。采用COX回归分析AIDS合并TB病人预后不良的影响因素。采用受试者工作特征曲线(ROC)分析这几项指标评估病人预后不良的价值。
      结果: 疗效不佳组病人CD4+T细胞、Th17细胞水平低于治疗有效组(P < 0.01),HIV载量、sCD14水平高于治疗有效组(P < 0.01)。高sCD14水平和低CD4+T细胞水平是AIDS合并TB病人疗效不佳的危险因素(OR = 1.798、2.260,P < 0.01)。单因素分析结果显示,低CD4+T细胞及Th17细胞水平、HIV病毒载量和sCD14水平与AIDS合并TB病人预后不良相关(P < 0.01)。多因素分析结果显示,高sCD14水平和低CD4+T细胞水平是AIDS合并TB病人预后不良的危险因素(P < 0.05)。CD4+T细胞、sCD14及两项指标联合评估AIDS合并TB病人预后不良的AUC分别为0.799、0.850、0.891,约登指数分别为0.468、0.693、0.701。
      结论: 基线高水平sCD14与低水平CD4+T细胞是AIDS合并TB病病人抗病毒治疗疗效不佳及预后不良的独立危险因素,联合检测此两项指标对识别高危病人具有潜在临床价值。

       

      Abstract:
      Objective To explore the association between the levels of soluble differentiation antigen 14 (sCD14), CD4+T cells and helper T cell 17 (Th17) in peripheral blood and therapeutic effect and prognosis of patients, and provide a reference for the early clinical identification of high-risk patients and optimization of treatment strategies.
      Methods A total of 102 patients with AIDS complicated with tuberculosis (TB) were selected, and divided into the effective-treatment group (71 cases) and ineffective-treatment group (31 cases) based on the efficacy of their antiretroviral therapy (ART). All patients were followed up for 2 years. Among the 102 patients, 22 cases had a poor prognosis and 80 cases had a good prognosis. The general information of the patients was collected, The peripheral blood sCD14 levels were measured by enzyme-linked immunosorbent assay (ELISA), The peripheral blood CD4+T cell count and Th17 cell proportion were determined by flow cytometry, and the plasma HIV viral load was detected by real-time quantitative PCR. Logistic regression was used to analyze the influencing factors of the therapeutic effect of ART treatment in AIDS patients complicated with TB. COX regression analysis was used to analyze the influencing factors of poor prognosis in AIDS patients complicated with TB. The receiver operating characteristic curve (ROC) was used to analyze the value of these indicators in evaluating poor prognosis of patients.
      Results The levels of CD4+T cells and Th17 cells in the ineffective-treatment group were lower than those in the effective treatment group, while the HIV load and sCD14 levels were higher than those in the effective treatment group (P < 0.05). High sCD14 levels and low CD4+T cell levels were the risk factors of poor treatment efficacy in AIDS patients complicated with TB (P < 0.05). The results of univariate analysis showed that the low levels of CD4+T cells and Th17 cells, HIV viral load and sCD14 were associated with poor prognosis in AIDS patients complicated with TB (P < 0.01). The AUCs of the CD4+T cells, sCD14 and combination of the two indicators for evaluating the poor prognosis of AIDS patients complicated with TB were 0.799, 0.850 and 0.891, respectively, and the Youden indices were 0.468, 0.693 and 0.701, respectively.
      Conclusions High baseline levels of sCD14 and low levels of CD4+T cells are the independent risk factors of poor antiviral treatment efficacy and prognosis in patients with AIDS complicated with TB disease. The combined detection of these two indicators has potential clinical value for identifying high-risk patients.

       

    /

    返回文章
    返回